Literature DB >> 8473889

Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain.

F Oyama1, H Shimada, R Oyama, K Titani, Y Ihara.   

Abstract

To learn whether or not the levels of beta-amyloid protein precursor (APP) and tau mRNAs are related to the formation of beta-amyloid and neurofibrillary tangles, we quantified these mRNA levels in three cortical regions of 38 aged human brains, which were examined immunocytochemically for beta-amyloid and tangles. Marked individual variabilities were noted in APP and tau mRNA levels among elderly individuals. The mean APP mRNA level was slightly reduced in the beta-amyloid plaque (+2) group, but not in the plaque (+) group, compared to the plaque (-) group. Some brains in the plaque (-) group showed increased APP expression, the extent of which was not seen in the plaque (+) or (+2) group. The differences in the mean tau mRNA levels were not statistically significant among the tangle (-), (+), and (+2) groups. These results show that beta-protein and tau deposition do not accompany increased expression of the APP and tau genes, respectively, and thus suggest that factors other than gene expression may be at work in the progression of beta-amyloid and/or tangle formation in the aged human brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473889     DOI: 10.1111/j.1471-4159.1993.tb13388.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.

Authors:  N B Chauhan; J M Lee; G J Siegel
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

2.  Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau.

Authors:  Bin Li; Muhammad Omar Chohan; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Acta Neuropathol       Date:  2007-03-20       Impact factor: 17.088

3.  Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2008-06-24       Impact factor: 4.673

4.  High-performance liquid chromatography coupled with tandem mass spectrometry for the detection of amyloid Beta peptide related with Alzheimer's disease.

Authors:  Chengan Du; Corinne Ramaley; Hugh McLean; Susan C Leonard; Jeff Miller
Journal:  J Biomol Tech       Date:  2005-12

5.  The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis".

Authors:  R A Armstrong
Journal:  Int J Alzheimers Dis       Date:  2011-02-07

6.  Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer's Disease: An Animal Model.

Authors:  Mudan Cai; Eun Jin Yang
Journal:  Front Pharmacol       Date:  2020-12-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.